Carlyle downgraded to In Line from Outperform at Evercore ISI

Evercore ISI downgraded Carlyle to In Line from Outperform with an unchanged price target of $32. The analyst cites valuation for the downgrade after the 25% move up in the stock in November and its addition to the S&P MidCap 400 Index. Carlyle continues to be more private equity centric than most, “where the healing is slow” and capital raising is challenging, the analyst tells investors in a research note.